CYTOTOXIC ACTIVITY OF TAXOL IN PRIMARY CULTURES OF TUMOR-CELLS FROM PATIENTS IS PARTLY MEDIATED BY CREMOPHOR EL

被引:49
作者
NYGREN, P
CSOKA, K
JONSSON, B
FRIDBORG, H
BERGH, J
HAGBERG, H
GLIMELIUS, B
BRODIN, O
THOLANDER, B
KREUGER, A
LONNERHOLM, G
JAKOBSSON, A
OLSEN, L
KRISTENSEN, J
LARSSON, R
机构
[1] UNIV UPPSALA HOSP, DIV CLIN PHARMACOL, S-75185 UPPSALA, SWEDEN
[2] UNIV UPPSALA HOSP, DEPT GYNECOL ONCOL, S-75185 UPPSALA, SWEDEN
[3] UNIV UPPSALA HOSP, DEPT PEDIAT, S-75185 UPPSALA, SWEDEN
[4] UNIV UPPSALA HOSP, DEPT PEDIAT SURG, S-75185 UPPSALA, SWEDEN
[5] UNIV UPPSALA HOSP, DEPT INTERNAL MED, S-75185 UPPSALA, SWEDEN
关键词
TAXOL; CREMOPHOR EL; PRIMARY CULTURE; TUMOR CELL;
D O I
10.1038/bjc.1995.97
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In patient tumour samples the activity in vitro of Taxol corresponded fairly well to the known clinical activity and Taxol showed low cross-resistance to standard cytotoxic drugs. However, the Taxol solvent Cremophor EL-ethanol was considerably active alone, whereas paclitaxel formulated in ethanol was less active. Taxol thus seems to contain two components active against patient tumour cells in vitro.
引用
收藏
页码:478 / 481
页数:4
相关论文
共 27 条
[1]   ALTERED PLASMA-MEMBRANE ULTRASTRUCTURE IN MULTIDRUG-RESISTANT CELLS [J].
ARSENAULT, AL ;
LING, V ;
KARTNER, N .
BIOCHIMICA ET BIOPHYSICA ACTA, 1988, 938 (02) :315-321
[2]  
BUDAVARI S, 1989, MERCK INDEX, P290
[3]   ONCOLYTIC EFFECTS OF FATTY-ACIDS IN MICE AND RATS [J].
BURTON, AF .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1991, 53 (04) :S1082-S1086
[4]  
CHANG A, 1992, P AM SOC CLIN ONCOL, V11, pA981
[5]  
COLTON T, 1974, STATISTICS MED
[6]   PHASE-II TRIAL OF TAXOL IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA [J].
EINZIG, AI ;
GOROWSKI, E ;
SASLOFF, J ;
WIERNIK, PH .
CANCER INVESTIGATION, 1991, 9 (02) :133-136
[7]   PHASE-II STUDY AND LONG-TERM FOLLOW-UP OF PATIENTS TREATED WITH TAXOL FOR ADVANCED OVARIAN ADENOCARCINOMA [J].
EINZIG, AI ;
WIERNIK, PH ;
SASLOFF, J ;
RUNOWICZ, CD ;
GOLDBERG, GL .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (11) :1748-1753
[8]  
FJALLSKOG ML, 1994, EUR J CANCER, V30A, P687
[9]   PHASE-II TRIAL OF TAXOL, AN ACTIVE-DRUG IN THE TREATMENT OF METASTATIC BREAST-CANCER [J].
HOLMES, FA ;
WALTERS, RS ;
THERIAULT, RL ;
FORMAN, AD ;
NEWTON, LK ;
RABER, MN ;
BUZDAR, AU ;
FRYE, DK ;
HORTOBAGYI, GN .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (24) :1797-1805
[10]   SDZ PSC-833 - A NOVEL POTENT INVITRO CHEMOSENSITIZER IN MULTIPLE-MYELOMA [J].
JONSSON, B ;
NILSSON, K ;
NYGREN, P ;
LARSSON, R .
ANTI-CANCER DRUGS, 1992, 3 (06) :641-646